Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Dulaglutide

Comparison of Injection Site Pain Experience for Semaglutide and Dulaglutide sc

Company n/r · Phase 4 · Completed · Enrollment 104

NCT04189848

Participants reaching a weight loss threshold

Participants reaching threshold, %

Source: Cited trial source. The denominator is the source figure, when it states one.

No selected arm reports a responder percent.

Show as table
Arm≥5%≥10%≥15%≥20%
Semaglutide followed by dulaglutiden/rn/rn/rn/r
Dulaglutide followed by semaglutiden/rn/rn/rn/r

Not shown

  • Semaglutide followed by dulaglutide: endpoint not reported
  • Dulaglutide followed by semaglutide: endpoint not reported